Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Breast cancer in the era of integrating “Omics” approaches
Cláudia Rossi, Ilaria Cicalini, Maria Concetta Cufaro, et al.
Oncogenesis (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

A systematic review of computational approaches to understand cancer biology for informed drug repurposing
Faheem Ahmed, Anupama Samantasinghar, Afaque Manzoor Soomro, et al.
Journal of Biomedical Informatics (2023) Vol. 142, pp. 104373-104373
Open Access | Times Cited: 34
Metabolomics of Breast Cancer: A Review
Ramadevi Subramani, Seeta Poudel, Kenneth Smith, et al.
Metabolites (2022) Vol. 12, Iss. 7, pp. 643-643
Open Access | Times Cited: 35
Clinical usefulness of NGS multi-gene panel testing in hereditary cancer analysis
Federico Anaclerio, Lucrezia Pilenzi, Anastasia Dell’Elice, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 17
Enhanced efficacy of β-carotene loaded solid lipid nanoparticles optimized and developed via central composite design on breast cancer cell lines
Rajat Subhra Dutta, Gamal Osman Elhassan, Takhellambam Bidyapati Devi, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28457-e28457
Open Access | Times Cited: 7
Comprehensive multi-omics analysis of breast cancer reveals distinct long-term prognostic subtypes
Abhibhav Sharma, Julia Debik, Bjørn Naume, et al.
Oncogenesis (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Image‐guided metabolomics and transcriptomics reveal tumour heterogeneity in luminal A and B human breast cancer beyond glucose tracer uptake
Qianlu Yang, Sisi Deng, Heike Preibsch, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 5
Proteomic meta-analysis unveils new frontiers for biomarkers research in pancreatic carcinoma
Federica Di Marco, Maria Concetta Cufaro, Verena Damiani, et al.
Oncogenesis (2025) Vol. 14, Iss. 1
Open Access
Multi-omics for disease subtyping and classification
Shimaa Sherif, Nagham Nafiz Hendi, Rania Alanany
Elsevier eBooks (2025), pp. 79-134
Closed Access
Multi-omic profiling in breast cancer: utility for advancing diagnostics and clinical care
Emna El Gazzah, Scott Parker, Mariaelena Pierobon
Expert Review of Molecular Diagnostics (2025)
Closed Access
Minocycline induced apoptosis and suppressed expression of matrix metalloproteinases 2 and 9 in the breast cancer MCF-7 cells
Abedeh Rezaei, Amin Moqadami, Mohammad Khalaj‐Kondori, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 4
Integrating functional proteomics and next generation sequencing reveals potential therapeutic targets for Taiwanese breast cancer
Wei‐Chi Ku, Chih-Yi Liu, Chi‐Jung Huang, et al.
Clinical Proteomics (2025) Vol. 22, Iss. 1
Open Access
Proteomics-Based Identification of Dysregulated Proteins in Breast Cancer
Anca-Narcisa Neagu, Madhuri Jayathirtha, Danielle Whitham, et al.
Proteomes (2022) Vol. 10, Iss. 4, pp. 35-35
Open Access | Times Cited: 17
PaCMAP-embedded convolutional neural network for multi-omics data integration
Hazem Qattous, Mohammad Azzeh, Rahmeh Ibrahim, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23195-e23195
Open Access | Times Cited: 10
New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer
Brahim El Hejjioui, Salma Lamrabet, Sarah Amrani Joutei, et al.
Diagnostics (2023) Vol. 13, Iss. 11, pp. 1949-1949
Open Access | Times Cited: 9
Integrating Proteomics and Lipidomics for Evaluating the Risk of Breast Cancer Progression: A Pilot Study
Natalia Starodubtseva, Alisa Tokareva, В. В. Родионов, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1786-1786
Open Access | Times Cited: 8
Novel computational biology modeling system can accurately forecast response to neoadjuvant therapy in early breast cancer
J.R. Peterson, John A. Cole, John R. Pfeiffer, et al.
Breast Cancer Research (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 7
Lipidomics and metabolomics as potential biomarkers for breast cancer progression
Alanis Carmona, Samir Mitri, Ted A. James, et al.
npj Metabolic Health and Disease (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 2
DNA repair pathways in breast cancer: from mechanisms to clinical applications
Muhammad Tufail
Breast Cancer Research and Treatment (2023) Vol. 200, Iss. 3, pp. 305-321
Closed Access | Times Cited: 6
Molecular mechanisms of multi-omic regulation in breast cancer
Soledad Ochoa, Enrique Hernández-Lemus
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
Targeting breast cancer stem cells directly to treat refractory breast cancer
Liping Pan, Juan Han, Ming Lin
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
GPR81-mediated reprogramming of glucose metabolism contributes to the immune landscape in breast cancer
Xiaofeng Li, Yiwen Chen, Ting Wang, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Circulating metabolites in the early stage of breast cancer were not related to cancer stage or subtypes but associated with ki67 level. Promising statistical discrimination from controls
Eva Baranovičová, Peter Račay, Pavol Žúbor, et al.
Molecular and Cellular Probes (2022) Vol. 66, pp. 101862-101862
Open Access | Times Cited: 8
Influence of the Microbiome Metagenomics and Epigenomics on Gastric Cancer
Precious Mathebela, Botle Precious Damane, Thanyani Victor Mulaudzi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13750-13750
Open Access | Times Cited: 8
Breast Cancer: How Hippotherapy Bridges the Gap between Healing and Recovery—A Randomized Controlled Clinical Trial
Hélène Viruega, Corinne Galy, Célia Loriette, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1317-1317
Open Access | Times Cited: 4
Realm of proteomics in breast cancer management and drug repurposing to alleviate intricacies of treatment
Rama N. Behera, Vinod S. Bisht, Kuldeep Giri, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2023) Vol. 17, Iss. 6
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top